From this article you will learn:
- release forms of the drug Viferon,
- instructions for use, reviews,
- clinical efficacy studies.
Viferon is a drug based on recombinant human interferon alpha-2b (Russian production), intended for the treatment of bacterial and viral infections. The drug is often prescribed for herpetic lesions of the oral mucosa in children. In addition to interferon alpha-2b, the drug contains vitamins E and C. The drug is considered safe and can be used even in newborns.
According to the manufacturer, Viferon has a large list of functional activities - primarily an antiviral effect, as well as immunomodulatory, antiproliferative and other properties. The drug has release forms - Viferon suppositories with dosages of 150,000 IU, 500,000 IU, 1,000,000 IU, 3,000,000 IU, as well as Viferon gel and ointment. The choice of release form will depend on the age of the child or adult, as well as on the location of the infectious focus (inflammation). The drug is intended for over-the-counter use.
Viferon candles: photo of packaging
For infants, the most convenient form is in the form of suppositories (candles). Accordingly, when using this form, the localization of the source of inflammation will be completely unimportant, because the drug will spread through the bloodstream. But for adults and children of middle and older age, of course, it is better to choose forms for topical use in the form of an ointment or gel. For various diseases, the choice of ointment and gel form is important.
For example, only Viferon-gel is suitable for application to the mucous membrane, because the gel form will adhere well to the moist mucosa. There is no point in applying Viferon ointment to mucous membranes. Remember that absolutely any preparations in the form of ointments or creams (i.e., fat-based) make sense to use only when the source of inflammation is localized on the skin of the face or the red border of the lips. In case of damage to the mucous membranes, preparations for topical use should only be in the form of gels.
Nosological classification (ICD-10)
- A41.9 Septicemia, unspecified
- A49.3 Mycoplasma infection, unspecified
- A59.0 Urogenital trichomoniasis
- A74.9 Chlamydial infection, unspecified
- B00.0 Herpetic eczema
- B00.1 Herpetic vesicular dermatitis
- B18 Chronic viral hepatitis
- B25.9 Cytomegalovirus disease, unspecified
- B34 Viral infection of unspecified localization
- B37.3 Candidiasis of the vulva and vagina (N77.1*)
- G03.9 Meningitis, unspecified
- J06 Acute upper respiratory tract infections of multiple and unspecified localization
- J11 Influenza, virus not identified
- J18 Pneumonia without specifying the pathogen
- N39.0 Urinary tract infection without established location
- N76 Other inflammatory diseases of the vagina and vulva
- O35.3 Fetal injury (suspected) due to maternal viral disease requiring maternal medical attention
- O35.8 Other fetal anomalies and lesions (suspected) requiring maternal medical attention
special instructions
For the treatment of a wide range of infectious and inflammatory diseases, Viferon can be used as part of combination therapy with antibacterial drugs, glucocorticoids, and immunosuppressive drugs.
There is evidence of the effectiveness of using the drug Viferon as part of complex therapy and for the prevention of the following diseases and conditions: herpetic infections, chlamydia, ureaplasmosis, toxoplasmosis, cytomegalovirus infection in adults and children over 1 year of age; viral hepatitis in adults, ARVI, influenza, bronchial asthma, juvenile rheumatoid arthritis; meningeal form of tick-borne encephalitis; prostatitis of various etiologies; purulent-septic postoperative complications, virus-associated glomerulonephritis, pyelonephritis.
Compound
Ointment for local and external use | 1 g |
active substance: | |
interferon human recombinant alpha-2 | 40000 IU |
excipients: tocopherol acetate - 0.02 g; anhydrous lanolin - 0.34 g; medical petroleum jelly - 0.45 g; peach oil - 0.12 g; purified water - up to 1 g |
Gel for local and external use | 1 g |
active substance: | |
interferon human recombinant alpha-2b | 36000 IU |
excipients: alpha-tocopherol acetate - 0.055 g; methionine - 0.0012 g; benzoic acid - 0.00128 mg; citric acid monohydrate - 0.001 g; sodium tetraborate decahydrate - 0.0018 mg; sodium chloride - 0.004 g; human serum albumin solution 10% - 0.02 g; distilled glycerin (glycerol) - 0.02 g; carmellose sodium - 0.02 g; ethanol 95% - 0.055 g; purified water - up to 1 g |
Suppositories for rectal use | 1 sup. |
active substance: | |
interferon human recombinant alpha-2b | 150000 IU |
500000 IU | |
1000000 IU | |
3000000 IU | |
excipients: alpha-tocopherol acetate - 0.055/0.055/0.055/0.055 g; ascorbic acid - 0.0054/0.0081/0.0081/0.0081 g; sodium ascorbate - 0.0108/0.0162/0.0162/0.0162 g; disodium edetate dihydrate - 0.0001/0.0001/0.0001/0.0001 g; polysorbate 80 - 0.0001/0.0001/0.0001/0.0001 g | |
base: cocoa butter and confectionery fat - up to 1 g |
Viferon for teething
I found it on the Internet, I’ll leave it here, it’ll come in handy.
First aid kit for babies